Nirmatrelvir/ritonavir and remdesivir against symptomatic treatment in high-risk COVID-19 outpatients to prevent hospitalization or death during the Omicron era: a propensity score-matched study
在奥密克戎时代,对高危 COVID-19 门诊患者进行对症治疗,以预防住院或死亡,尼马替尼/利托那韦和瑞德西韦的疗效比较:一项倾向评分匹配研究
期刊:Therapeutic Advances in Infectious Disease
影响因子:3.4
doi:10.1177/20499361241236582
Rajme-López, Sandra; Martinez-Guerra, Bernardo A; Román-Montes, Carla M; Tamez-Torres, Karla M; Tello-Mercado, Andrea C; Tepo-Ponce, Karen M; Segura-Ortíz, Zurisadai; López-Aguirre, Abigail; Gutiérrez-Mazariegos, Orianlid Del Rocío; Lazcano-Delgadillo, Oswaldo; Nares-López, Rafael; González-Lara, María F; Kershenobich-Stalnikowitz, David; Sifuentes-Osornio, José; Ponce-de-León, Alfredo; Ruíz-Palacios, Guillermo M